PROTEOLIPOSOMAS Y SUS DERIVADOS COMO ADYUVANTES INDUCTORES DE RESPUESTA CITOTOXICA Y LAS FORMULACIONES RESULTANTES

PROTEOLIPOSOMAS Y SUS DERIVADOS COMO ADYUVANTES INDUCTORES DE RESPUESTA CITOTOXICA Y LAS FORMULACIONES RESULTANTES

The invention relates to the field of vaccine compositions for the effective treatment or prevention of fungal, viral, protozoan or bacterial (preferable intracellular) infections and cancer. The technical objective of the invention is to obtain adjuvants for use in prophylactic or therapeutic vacci...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: BRACHO GRANADO, GUSTAVO RAFAEL, DEL CAMPO ALONSO, JUDITH MONICA, LASTRE GONZALEZ, MIRIAM DE SAN JUAN BOSCO, MASTROENI, PIETRO, RODRIGUEZ RAMIREZ, TAMARA, PEREZ MARTIN, OLIVER GERMAN
Format: Patent
Sprache:spa
Schlagworte:
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator BRACHO GRANADO, GUSTAVO RAFAEL
DEL CAMPO ALONSO, JUDITH MONICA
LASTRE GONZALEZ, MIRIAM DE SAN JUAN BOSCO
MASTROENI, PIETRO
RODRIGUEZ RAMIREZ, TAMARA
PEREZ MARTIN, OLIVER GERMAN
description The invention relates to the field of vaccine compositions for the effective treatment or prevention of fungal, viral, protozoan or bacterial (preferable intracellular) infections and cancer. The technical objective of the invention is to obtain adjuvants for use in prophylactic or therapeutic vaccines using bacterial proteoliposomes and derivatives thereof, which, when applied, together with antigens that are inserted in, conjugated to or mixed with same, induce a cytotoxic T-lymphocyte response to the aforementioned antigen. In this way the invention can be used to obtain multiple formulations of proteoliposome or the derivatives thereof with heterologous antigens, which, when applied by parenteral or mucosal (preferably nasal) routes, induce cytotoxic responses. Said novel use of proteoliposomes and the derivatives thereof and the resulting antigen formulations can be used to produce novel vaccines in the pharmaceutical industry.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_ES2301418B1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>ES2301418B1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_ES2301418B13</originalsourceid><addsrcrecordid>eNqNzLEKwjAQgOEuDqK-w72AYK2D65mkGEh7JXcp7VSKxEm0WN8fo_gATv_y8S-zZ-NJDDnbEFOFDD1wYNDG2xY1MSiqCFD3ocVaDIOtdVBC3nwQpDTBsCAoKyTUWYVp4dKoJF8Fh8pSnWyCwcl3sc4W1_E2x82vqwxKI-q8jdNjiPM0XuI9vgbD-2KXH_LjKS_-IG9nBjjs</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>PROTEOLIPOSOMAS Y SUS DERIVADOS COMO ADYUVANTES INDUCTORES DE RESPUESTA CITOTOXICA Y LAS FORMULACIONES RESULTANTES</title><source>esp@cenet</source><creator>BRACHO GRANADO, GUSTAVO RAFAEL ; DEL CAMPO ALONSO, JUDITH MONICA ; LASTRE GONZALEZ, MIRIAM DE SAN JUAN BOSCO ; MASTROENI, PIETRO ; RODRIGUEZ RAMIREZ, TAMARA ; PEREZ MARTIN, OLIVER GERMAN</creator><creatorcontrib>BRACHO GRANADO, GUSTAVO RAFAEL ; DEL CAMPO ALONSO, JUDITH MONICA ; LASTRE GONZALEZ, MIRIAM DE SAN JUAN BOSCO ; MASTROENI, PIETRO ; RODRIGUEZ RAMIREZ, TAMARA ; PEREZ MARTIN, OLIVER GERMAN</creatorcontrib><description>The invention relates to the field of vaccine compositions for the effective treatment or prevention of fungal, viral, protozoan or bacterial (preferable intracellular) infections and cancer. The technical objective of the invention is to obtain adjuvants for use in prophylactic or therapeutic vaccines using bacterial proteoliposomes and derivatives thereof, which, when applied, together with antigens that are inserted in, conjugated to or mixed with same, induce a cytotoxic T-lymphocyte response to the aforementioned antigen. In this way the invention can be used to obtain multiple formulations of proteoliposome or the derivatives thereof with heterologous antigens, which, when applied by parenteral or mucosal (preferably nasal) routes, induce cytotoxic responses. Said novel use of proteoliposomes and the derivatives thereof and the resulting antigen formulations can be used to produce novel vaccines in the pharmaceutical industry.</description><language>spa</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2009</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20090501&amp;DB=EPODOC&amp;CC=ES&amp;NR=2301418B1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20090501&amp;DB=EPODOC&amp;CC=ES&amp;NR=2301418B1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>BRACHO GRANADO, GUSTAVO RAFAEL</creatorcontrib><creatorcontrib>DEL CAMPO ALONSO, JUDITH MONICA</creatorcontrib><creatorcontrib>LASTRE GONZALEZ, MIRIAM DE SAN JUAN BOSCO</creatorcontrib><creatorcontrib>MASTROENI, PIETRO</creatorcontrib><creatorcontrib>RODRIGUEZ RAMIREZ, TAMARA</creatorcontrib><creatorcontrib>PEREZ MARTIN, OLIVER GERMAN</creatorcontrib><title>PROTEOLIPOSOMAS Y SUS DERIVADOS COMO ADYUVANTES INDUCTORES DE RESPUESTA CITOTOXICA Y LAS FORMULACIONES RESULTANTES</title><description>The invention relates to the field of vaccine compositions for the effective treatment or prevention of fungal, viral, protozoan or bacterial (preferable intracellular) infections and cancer. The technical objective of the invention is to obtain adjuvants for use in prophylactic or therapeutic vaccines using bacterial proteoliposomes and derivatives thereof, which, when applied, together with antigens that are inserted in, conjugated to or mixed with same, induce a cytotoxic T-lymphocyte response to the aforementioned antigen. In this way the invention can be used to obtain multiple formulations of proteoliposome or the derivatives thereof with heterologous antigens, which, when applied by parenteral or mucosal (preferably nasal) routes, induce cytotoxic responses. Said novel use of proteoliposomes and the derivatives thereof and the resulting antigen formulations can be used to produce novel vaccines in the pharmaceutical industry.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2009</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNzLEKwjAQgOEuDqK-w72AYK2D65mkGEh7JXcp7VSKxEm0WN8fo_gATv_y8S-zZ-NJDDnbEFOFDD1wYNDG2xY1MSiqCFD3ocVaDIOtdVBC3nwQpDTBsCAoKyTUWYVp4dKoJF8Fh8pSnWyCwcl3sc4W1_E2x82vqwxKI-q8jdNjiPM0XuI9vgbD-2KXH_LjKS_-IG9nBjjs</recordid><startdate>20090501</startdate><enddate>20090501</enddate><creator>BRACHO GRANADO, GUSTAVO RAFAEL</creator><creator>DEL CAMPO ALONSO, JUDITH MONICA</creator><creator>LASTRE GONZALEZ, MIRIAM DE SAN JUAN BOSCO</creator><creator>MASTROENI, PIETRO</creator><creator>RODRIGUEZ RAMIREZ, TAMARA</creator><creator>PEREZ MARTIN, OLIVER GERMAN</creator><scope>EVB</scope></search><sort><creationdate>20090501</creationdate><title>PROTEOLIPOSOMAS Y SUS DERIVADOS COMO ADYUVANTES INDUCTORES DE RESPUESTA CITOTOXICA Y LAS FORMULACIONES RESULTANTES</title><author>BRACHO GRANADO, GUSTAVO RAFAEL ; DEL CAMPO ALONSO, JUDITH MONICA ; LASTRE GONZALEZ, MIRIAM DE SAN JUAN BOSCO ; MASTROENI, PIETRO ; RODRIGUEZ RAMIREZ, TAMARA ; PEREZ MARTIN, OLIVER GERMAN</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_ES2301418B13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>spa</language><creationdate>2009</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>BRACHO GRANADO, GUSTAVO RAFAEL</creatorcontrib><creatorcontrib>DEL CAMPO ALONSO, JUDITH MONICA</creatorcontrib><creatorcontrib>LASTRE GONZALEZ, MIRIAM DE SAN JUAN BOSCO</creatorcontrib><creatorcontrib>MASTROENI, PIETRO</creatorcontrib><creatorcontrib>RODRIGUEZ RAMIREZ, TAMARA</creatorcontrib><creatorcontrib>PEREZ MARTIN, OLIVER GERMAN</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>BRACHO GRANADO, GUSTAVO RAFAEL</au><au>DEL CAMPO ALONSO, JUDITH MONICA</au><au>LASTRE GONZALEZ, MIRIAM DE SAN JUAN BOSCO</au><au>MASTROENI, PIETRO</au><au>RODRIGUEZ RAMIREZ, TAMARA</au><au>PEREZ MARTIN, OLIVER GERMAN</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>PROTEOLIPOSOMAS Y SUS DERIVADOS COMO ADYUVANTES INDUCTORES DE RESPUESTA CITOTOXICA Y LAS FORMULACIONES RESULTANTES</title><date>2009-05-01</date><risdate>2009</risdate><abstract>The invention relates to the field of vaccine compositions for the effective treatment or prevention of fungal, viral, protozoan or bacterial (preferable intracellular) infections and cancer. The technical objective of the invention is to obtain adjuvants for use in prophylactic or therapeutic vaccines using bacterial proteoliposomes and derivatives thereof, which, when applied, together with antigens that are inserted in, conjugated to or mixed with same, induce a cytotoxic T-lymphocyte response to the aforementioned antigen. In this way the invention can be used to obtain multiple formulations of proteoliposome or the derivatives thereof with heterologous antigens, which, when applied by parenteral or mucosal (preferably nasal) routes, induce cytotoxic responses. Said novel use of proteoliposomes and the derivatives thereof and the resulting antigen formulations can be used to produce novel vaccines in the pharmaceutical industry.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language spa
recordid cdi_epo_espacenet_ES2301418B1
source esp@cenet
subjects HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
title PROTEOLIPOSOMAS Y SUS DERIVADOS COMO ADYUVANTES INDUCTORES DE RESPUESTA CITOTOXICA Y LAS FORMULACIONES RESULTANTES
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-23T09%3A57%3A25IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=BRACHO%20GRANADO,%20GUSTAVO%20RAFAEL&rft.date=2009-05-01&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EES2301418B1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true